Full-Time

Frontend Software Engineer

Collate

Collate

11-50 employees

AI-driven documentation automation for life sciences

Compensation Overview

$150k - $350k/yr

+ Equity

San Francisco, CA, USA

In Person

Category
Software Engineering (1)
Required Skills
UI/UX Design
React.js
TypeScript
Requirements
  • Strong experience building modern web applications with React, TypeScript, or similar frameworks.
Responsibilities
  • Build responsive, performant web applications that make complex AI-driven healthcare data simple, accessible and usable.
Desired Qualifications
  • Next.js and Tailwind experience is a plus.
  • A deep care for design, usability, and accessibility — you see frontend engineering as product design.
  • The ability to translate complex, technical concepts into simple, intuitive user experiences.
  • Comfort working across the stack when needed, with a passion for owning the frontend experience.
  • A track record of shipping high-quality features quickly while maintaining technical rigor in complex systems.
  • Motivation to work in an early-stage startup where your contributions directly shape both product and culture.

Collate provides an AI-powered platform that automates the creation and management of documentation for drug development, medical devices, and diagnostics. It works by generating, organizing, and governing regulatory and quality documents while offering data discovery and governance tools to ensure high-quality data assets. It distinguishes itself by offering an end-to-end, life-sciences–focused solution that covers drug, device, and diagnostic workflows in one platform, reducing manual work and speeding up approvals. Its goal is to shorten development and regulatory timelines so researchers can focus on discovery and bring life-saving innovations to patients faster.

Company Size

11-50

Company Stage

Seed

Total Funding

$30M

Headquarters

San Francisco, California

Founded

2025

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's 20% manufacturing throughput gains validate AI documentation automation market demand.[5]
  • UCSF ARPA-H funding accelerates open-source drug development, creating IND filing opportunities.[5]
  • Moderna's AWS AI integration demonstrates enterprise adoption of automated quality control workflows.[5]

What critics are saying

  • Pfizer's proprietary generative AI platform directly competes in manufacturing documentation automation.[5]
  • FDA's DARRTS system with AI language models bypasses Collate's regulatory submission tools.[7]
  • Open-source models from UCSF and Open Molecular Software Foundation commoditize documentation automation.[5]

What makes Collate unique

  • Acquired MantleBio to deepen AI capabilities across entire drug development lifecycle.[1]
  • Generative AI automates regulatory submissions, clinical trials, and quality management workflows.[2][3]
  • AI Studio and SDK enable custom agents without external infrastructure dependencies.[8]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

Flexible Work Hours

Professional Development Budget

Company News

The American Bazaar
Jan 21st, 2025
Collate secures $30M to automate paperwork

Biotech startup Collate, founded by Surbhi Sarna, has secured a $30 million seed fund to automate paperwork in the life sciences industry using AI. The funding round was led by Redpoint, with participation from First Round, Conviction Partners, and YC, valuing Collate at over $100 million. Collate aims to streamline documentation for diagnostic, medical device, and drug development companies, enhancing R&D and reducing time to market. Co-founders Nate Smith and Jigish Patel bring additional expertise.

Forbes
Jan 13th, 2025
This YC Partner Just Raised $30 Million For An AI Startup Automating Paperwork For Biotech

Y Combinator's Surbhi Sarna has raised $30 million for Collate, a startup aiming to automate the tedious parts of running a life sciences business using AI.